Moreover, co-occurring patterns were also found between RBM10 and PIK3CA, as well as between TP53 and ERBB2 and marginally significant enrichment of SETD2 mutations, in samples with oncogene fusions, particularly in TP53-proficient tumours. The gene discussed is TP53; the disease is neoplasm.